Credit Suisse’s Medifast MED Stock Holding History

Credit Suisse’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-7,900	Closed	-$866K	–	4151
2019 Q4	$866K	Hold	7,900	–	–	﹤0.01%	3235
2019 Q3	$819K	Buy	+7,900	New	+$849K	﹤0.01%	3143

Other funds holding MED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $39.3B AUM 27.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Credit Suisse's MED Position: Q1 2024 in Review

Credit Suisse held its Medifast (MED) position steady in Q1 2024 at 12,622 shares worth $484K. The position accounts for ﹤0.01% of the portfolio, ranked #2656.

Credit Suisse first reported a position in MED in Q2 2013 and has held it in 44 quarters since. The position peaked at $69.7M in Q2 2020. 186 funds tracked by Wall St. Rank hold MED as of Q1 2024.

Credit Suisse held 12,622 shares of Medifast worth $484K as of Q1 2024.
Credit Suisse left its Medifast share count unchanged in Q1 2024.
Medifast made up ﹤0.01% of Credit Suisse's portfolio in Q1 2024, its #2656 holding.
Credit Suisse first reported a position in Medifast in Q2 2013 and has held it in 44 quarters since.
Credit Suisse's Medifast position peaked at $69.7M in Q2 2020.
186 funds tracked by Wall St. Rank held Medifast as of Q1 2024.

Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.